Cough syrup deaths: CDSCO launches risk-based inspection at manufacturing units of 19 drugs

India's drug regulator, CDSCO, initiated risk-based inspections at 19 drug manufacturing units, including cough syrups, across six states following child deaths in Madhya Pradesh. Coldrif Cough Syrup from Tamil Nadu's Sresan Pharma was later found to contain excessive Diethylene Glycol, leading to a statewide ban and facility inspections.

from Industry-Economic Times https://ift.tt/G5Tveyh
via IFTTT